Articles dans des revues avec comité de lecture (110)
  1. 32. Wolking, S., Schulz, H., Nies, A. A., McCormack, M., Schaeffeler, E., Auce, P., Avbersek, A., Becker, F., Klein, K. M., Krenn, M., Møller, R. S., Nikanorova, M., Weckhuysen, S., Consortium, E. P., Cavalleri, G., Delanty, N., Depondt, C., Johnson, M., Koeleman, B., Kunz, W. W., Marson, A. G., Sander, J. W., Sills, G., Striano, P., Zara, F., Zimprich, F., Weber, Y. Y., Krause, R., Sisodiya, S., Schwab, M., Sander, T., & Lerche, H. (2020). Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study. Pharmacogenomics, 21(5), 325-335. doi:10.2217/pgs-2019-0179
  2. 33. Grasby, K., Depondt, C., & et, A. (2020). The genetic architecture of the human cerebral cortex. Science, 367.
  3. 34. Thorpe, J., Ashby, S., Hallab, A., Ding, D., Andraus, M., Dugan, P., Perucca, P., Costello, D., French, J. J., O'Brien, T. J., Depondt, C., Andrade, D., Sengupta, R., Delanty, N., Jette, N., Newton, C. C., Brodie, M. J., Devinsky, O. I., Helen Cross, J., Sander, J. W., Hanna, J., & Sen, A. (2020). Evaluating risk to people with epilepsy during the COVID-19 pandemic: Preliminary findings from the COV-E study. Epilepsy & behavior., 107658. doi:10.1016/j.yebeh.2020.107658
  4. 35. Satizabal, C., Depondt, C., et al. (2019). Genetic architecture of subcortical brain structures in 38,851 individuals. Nature genetics.
  5. 36. Leu, C., Depondt, C., Epi25 Collaborative,, et al. (2019). Polygenic burden in focal and generalized epilepsies. Brain.
  6. 37. Heavin, S., McCormack, M., Wolking, S., Slattery, L., Walley, N., Avbersek, A., Novy, J., Sinha, S. S., Radtke, R., Doherty, C. P., Auce, P., Craig, J., Johnson, M., Koeleman, B., Krause, R., Kunz, W. W., Marson, A. G., O'Brien, T. J., Sander, J. W., Sills, G., Stefansson, H., Striano, P., Zara, F., Depondt, C., Sisodiya, S., Goldstein, D., Lerche, H., Cavalleri, G., & Delanty, N. (2019). Genomic and clinical predictors of lacosamide response in refractory epilepsies. Epilepsia Open. doi:10.1002/epi4.12360
  7. 38. Silvennoinen, K., Depondt, C., Brodie, M. J., Chinthapalli, K., de Haan, G. J., Doherty, C. P., Heavin, S., McCormack, M., Petrovski, S., Sargsyan, N., Slattery, L., & Willis, J. (2019). Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy. Epilepsia Open, 4(3), 420-430. doi:10.1002/epi4.12349
  8. 39. Epi25 Collaborative,, Depondt, C., et al. (2019). Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals. American journal of human genetics.
  9. 40. Conte, F., Van Paesschen, W., Legros, B., & Depondt, C. (2019). The Epilepsy Surgery Grading Scale: Validation in an independent population with drug-resistant focal epilepsy. Epilepsia, 60(8), e78-e82. doi:10.1111/epi.16096
  10. 41. Berghuis, B., Stapleton, C., Sonsma, A. A., Hulst, J., de Haan, G. J., Lindhout, D., Demurtas, R., Krause, R., Depondt, C., Kunz, W. W., Zara, F., Striano, P., Craig, J., Auce, P., Marson, A. G., Stefansson, H., O'Brien, T. J., Johnson, M., Sills, G., Wolking, S., Lerche, H., Sisodiya, S., Sander, L. J., Cavalleri, G., Koeleman, B. B., & McCormack, M. (2019). A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. Epilepsia Open, 4(1), 102-109. doi:10.1002/epi4.12297
  11. 42. Scoppettuolo, P., Gaspard, N., Depondt, C., Legros, B., Ligot, N., & Naeije, G. (2019). Epileptic activity in neurological deterioration after ischemic stroke, a continuous EEG study. Clinical neurophysiology. doi:10.1016/j.clinph.2019.09.005
  12. 43. Sambin, S., Gaspard, N., Legros, B., Depondt, C., De Breucker, S., & Naeije, G. (2019). Role of Epileptic Activity in Older Adults With Delirium, a Prospective Continuous EEG Study. Frontiers in neurology, 10, 263. doi:10.3389/fneur.2019.00263
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>